EP
IDYA icon

Essential Partners’s IDEAYA Biosciences IDYA Stock Holding History

Essential Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Buy
30
+25
+500% +$765 ﹤0.01% 2194
2026
Q1 		$167 Hold
5
– – ﹤0.01% 2645
2025
Q4 		$173 Hold
5
– – ﹤0.01% 2457
2025
Q3 		$136 Hold
5
– – ﹤0.01% 2458
2025
Q2 		$105 Buy
+5
New +$96 ﹤0.01% 2057

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Essential Partners's IDYA Position: Q2 2026 in Review

Essential Partners increased its IDEAYA Biosciences (IDYA) stake by 500% in Q2 2026, buying an estimated $765 and bringing the position to 30 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Essential Partners first reported a position in IDYA in Q2 2025 and has held it in 5 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Essential Partners held 30 shares of IDEAYA Biosciences worth $1.12K as of Q2 2026.
  • Essential Partners bought 25 IDEAYA Biosciences shares in Q2 2026, an estimated $765.
  • IDEAYA Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2194 holding.
  • Essential Partners first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.